Zedrock Technologies And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 50.95%
- Profit Growth 65.15%
- Ebitda 48.12%
- Net Worth 129.61%
- Total Assets 99.65%
About Zedrock Technologies And Pharmaceuticals
Zedrock Technologies And Pharmaceuticals Private Limited (ZTAPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 April 2017 (Seven years and nine months 23 days old ). Its registered office is in Allahabad, Uttar Pradesh, India.
The Corporate was formerly known as Zedrock Technologies Private Limited. The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjaya Asthana, Shalini Asthana, Meghna Asthana, and One other member serve as directors at the Company.
Company Details
-
Location
Allahabad, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100UP2017PTC092312
-
Company No.
092312
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Apr 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Zedrock Technologies And Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Meghna Asthana
|
Director | 18-Apr-2017 | Current |
|
Anvita Asthana
|
Additional Director | 14-Nov-2019 | Current |
|
Sanjaya Asthana
|
Additional Director | 01-Dec-2023 | Current |
|
Shalini Asthana
|
Director | 18-Apr-2017 | Current |
Financial Performance of Zedrock Technologies And Pharmaceuticals.
Zedrock Technologies And Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 50.95% increase. The company also saw a substantial improvement in profitability, with a 65.15% increase in profit. The company's net worth Soared by an impressive increase of 129.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zedrock Technologies And Pharmaceuticals?
In 2019, Zedrock Technologies And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Honey Dew Design Studio Private LimitedSanjaya Asthana and Anvita Asthana are mutual person
-
Prayag Health Care & Research Centre Private Limited
Sanjaya Asthana is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zedrock Technologies And Pharmaceuticals?
Unlock and access historical data on people associated with Zedrock Technologies And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zedrock Technologies And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zedrock Technologies And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.